Concepedia

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial

Heather Platt, Tosin Omole, José F. Cardona, Neil J. Fraser, Richard A. Mularski, Charles M. Andrews, Nizar Daboul, Nancy Gallagher, Aditi Sapre, Jianing Li,

The Lancet Infectious Diseases · 2022 · 82 citations · 17 references

DOI

Concepts

References

17

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

C. J. Clopper, E. S. Pearson · Biometrika · 1934 · 4.8K citations

, , +16

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

Tamara Pilishvili, Catherine Lexau, Monica M. Farley et al. · The Journal of Infectious Diseases · 2009 · 1.3K citations · Full text

, , +17

Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15

Brian Wahl, Katherine L. O’Brien, Adena Greenbaum et al. · The Lancet Global Health · 2018 · 1.2K citations · Full text

, , +17

Comparative analysis of two rates

Olli S. Miettinen, Markku Nurminen · Statistics in Medicine · 1985 · 1.1K citations

, , +16

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

Daniel R. Feikin, E. Wangeci Kagucia, Jennifer D. Loo et al. · PLoS Medicine · 2013 · 480 citations · Full text

, , +16